Literature DB >> 27212249

Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinence.

Nuria Garcia-Marchena1, Francisco J Pavon1, Antoni Pastor2,3,4, Pedro Araos1, Maria Pedraz1, Pablo Romero-Sanchiz1, Montserrat Calado1, Juan Suarez1, Estela Castilla-Ortega1, Laura Orio5, Anna Boronat2,3,4, Marta Torrens6,7,8, Gabriel Rubio9,10, Rafael de la Torre2,4,11, Fernando Rodriguez de Fonseca1, Antonia Serrano1.   

Abstract

Acylethanolamides are a family of endogenous lipid mediators that are involved in physiological and behavioral processes associated with addiction. Recently, oleoylethanolamide (OEA) has been reported to reduce alcohol intake and relapse in rodents but the contribution of OEA and other acylethanolamides in alcohol addiction in humans is unknown. The present study is aimed to characterize the plasma acylethanolamides in alcohol dependence. Seventy-nine abstinent alcohol-dependent subjects (27 women) recruited from outpatient treatment programs and age-/sex-/body mass-matched healthy volunteers (28 women) were clinically assessed with the diagnostic interview PRISM according to the DSM-IV-TR after blood extraction for quantification of acylethanolamide concentrations in the plasma. Our results indicate that all acylethanolamides were significantly increased in alcohol-dependent patients compared with control subjects (p < 0.001). A logistic model based on these acylethanolamides was developed to distinguish alcohol-dependent patients from controls and included OEA, arachidonoylethanolamide (AEA) and docosatetraenoylethanolamide (DEA), providing a high discriminatory power according to area under the curve [AUC = 0.92 (95%CI: 0.87-0.96), p < 0.001]. Additionally, we found a significant effect of the duration of alcohol abstinence on the concentrations of OEA, AEA and DEA using a regression model (p < 0.05, p < 0.01 and p < 0.001, respectively), which was confirmed by a negative correlation (rho = -0.31, -0.40 and -0.44, respectively). However, acylethanolamides were not influenced by the addiction alcohol severity, duration of problematic alcohol use or diagnosis of psychiatric comorbidity. Our results support the preclinical studies and suggest that OEA, AEA and DEA are altered in alcohol-dependence during abstinence and that might act as potential markers for predicting length of alcohol abstinence.
© 2016 Society for the Study of Addiction.

Entities:  

Keywords:  DSM-IV-TR; abstinence; acylethanolamides; alcohol use disorder; oleoylethanolamide; psychiatric comorbidity

Mesh:

Substances:

Year:  2016        PMID: 27212249     DOI: 10.1111/adb.12408

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  10 in total

1.  Ethanol-induced alterations in endocannabinoids and relevant neurotransmitters in the nucleus accumbens of fatty acid amide hydrolase knockout mice.

Authors:  Francisco J Pavón; Antonia Serrano; David G Stouffer; Ilham Polis; Marisa Roberto; Benjamin F Cravatt; Rémi Martin-Fardon; Fernando Rodríguez de Fonseca; Loren H Parsons
Journal:  Addict Biol       Date:  2018-11-13       Impact factor: 4.280

2.  Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURB.

Authors:  Laura M Best; Belinda Williams; Bernard Le Foll; Esmaeil Mansouri; Richard P Bazinet; Lin Lin; Vincenzo De Luca; Dina Lagzdins; Pablo Rusjan; Rachel F Tyndale; Alan A Wilson; Christian S Hendershot; Markus Heilig; Sylvain Houle; Junchao Tong; Stephen J Kish; Isabelle Boileau
Journal:  Neuropsychopharmacology       Date:  2020-01-07       Impact factor: 7.853

3.  Cessation of fluoxetine treatment increases alcohol seeking during relapse and dysregulates endocannabinoid and glutamatergic signaling in the central amygdala.

Authors:  Juan Suárez; Sophia Khom; Francisco Alén; Luis A Natividad; Florence P Varodayan; Reesha R Patel; Dean Kirson; Rocío Arco; Antonio Ballesta; Michal Bajo; Leticia Rubio; Rémi Martin-Fardon; Fernando Rodríguez de Fonseca; Marisa Roberto
Journal:  Addict Biol       Date:  2019-07-24       Impact factor: 4.280

Review 4.  Distinct functions of endogenous cannabinoid system in alcohol abuse disorders.

Authors:  Balapal S Basavarajappa; Vikram Joshi; Madhu Shivakumar; Shivakumar Subbanna
Journal:  Br J Pharmacol       Date:  2019-07-29       Impact factor: 8.739

5.  N-acylethanolamine acid amidase (NAAA) inhibition decreases the motivation for alcohol in Marchigian Sardinian alcohol-preferring rats.

Authors:  Yannick Fotio; Roberto Ciccocioppo; Daniele Piomelli
Journal:  Psychopharmacology (Berl)       Date:  2020-10-10       Impact factor: 4.530

6.  Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder.

Authors:  Sandra Torres Galván; María Flores-López; Pablo Romero-Sanchiz; Nerea Requena-Ocaña; Oscar Porras-Perales; Raquel Nogueira-Arjona; Fermín Mayoral; Pedro Araos; Antonia Serrano; Roberto Muga; Francisco Javier Pavón; Nuria García-Marchena; Fernando Rodríguez de Fonseca
Journal:  Sci Rep       Date:  2021-07-01       Impact factor: 4.379

7.  Higher Impulsivity As a Distinctive Trait of Severe Cocaine Addiction among Individuals Treated for Cocaine or Alcohol Use Disorders.

Authors:  Nuria García-Marchena; David Ladrón de Guevara-Miranda; María Pedraz; Pedro Fernando Araos; Gabriel Rubio; Juan Jesús Ruiz; Francisco Javier Pavón; Antonia Serrano; Estela Castilla-Ortega; Luis J Santín; Fernando Rodríguez de Fonseca
Journal:  Front Psychiatry       Date:  2018-02-13       Impact factor: 4.157

8.  Oleoylethanolamide Modulates BDNF-ERK Signaling and Neurogenesis in the Hippocampi of Rats Exposed to Δ9-THC and Ethanol Binge Drinking During Adolescence.

Authors:  Daniel Silva-Peña; Patricia Rivera; Francisco Alén; Antonio Vargas; Leticia Rubio; Nuria García-Marchena; Francisco Javier Pavón; Antonia Serrano; Fernando Rodríguez de Fonseca; Juan Suárez
Journal:  Front Mol Neurosci       Date:  2019-04-24       Impact factor: 5.639

9.  Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients.

Authors:  Nuria García-Marchena; Nieves Pizarro; Francisco J Pavón; Miriam Martínez-Huélamo; María Flores-López; Nerea Requena-Ocaña; Pedro Araos; Daniel Silva-Peña; Juan Suárez; Luis J Santín; Rafael de la Torre; Fernando Rodríguez de Fonseca; Antonia Serrano
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

10.  Effects of Adolescent Intermittent Alcohol Exposure on the Expression of Endocannabinoid Signaling-Related Proteins in the Spleen of Young Adult Rats.

Authors:  Francisco Javier Pavón; Eva María Marco; Mariam Vázquez; Laura Sánchez; Patricia Rivera; Ana Gavito; Virginia Mela; Francisco Alén; Juan Decara; Juan Suárez; Elena Giné; José Antonio López-Moreno; Julie Chowen; Fernando Rodríguez-de-Fonseca; Antonia Serrano; María Paz Viveros
Journal:  PLoS One       Date:  2016-09-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.